If you have been reading about Dihexa and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | For lyophilized powder; avoid repeated freeze-thaw. |
| Appearance | White to off-white powder | Common for lyophilized peptides. |
| Solubility | Soluble in water and aqueous buffers | Limited solubility in nonpolar solvents. |
| Typical analytical method | Reverse-phase HPLC and mass spectrometry | Used for purity and identity checks. |
| Typical purity specification | 95% or greater by HPLC area | Supplier values vary; not a biological potency measure. |
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Large very-low-density lipoprotein particles (VLDL-P) Small low-density lipoprotein particles (LDL-P) Large high-density lipoprotein particles (HDL-P) VLDL size LDL size HDL size These markers assess lipid metabolism linked to insulin resistance, in which cells respond poorly to insulin, often preceding type 2 diabetes and cardiovascular disease. Multiple studies, reported that it predicts future type 2 diabetes risk effectively, even outperforming traditional markers like fasting glucose in some cases. The LP-IR score offers early detection of insulin resistance, even in people with normal blood glucose, making it useful for preventive health strategies. It is simple, affordable, and doesn't require insulin or glucose measurements, avoiding issues with insulin assay variability.
Dehydroepiandrosterone (DHEA), also known as androstenolone, is an endogenous steroid hormone precursor. It is one of the most abundant circulating steroids in humans. DHEA is produced in the adrenal glands, the gonads, and the brain. It functions as a metabolic intermediate in the biosynthesis of the androgen and estrogen sex steroids both in the gonads and in various other tissues. However, DHEA also has a variety of potential biological effects in its own right, binding to an array of nuclear and cell surface receptors, and acting as a neurosteroid and modulator of neurotrophic factor receptors. In the United States, DHEA is sold as an over-the-counter supplement, and medication called prasterone.
===== Reverse transcription ===== One way of doing this is to develop nucleotide or nucleoside analogues that look like the building blocks of RNA or DNA, but deactivate the enzymes that synthesize the RNA or DNA once the analogue is incorporated. This approach is more commonly associated with the inhibition of reverse transcriptase (RNA to DNA) than with "normal" transcriptase (DNA to RNA). The first successful antiviral, aciclovir, is a nucleoside analogue, and is effective against herpesvirus infections. The first antiviral drug to be approved for treating HIV, zidovudine (AZT), is also a nucleoside analogue. An improved knowledge of the action of reverse transcriptase has led to better nucleoside analogues to treat HIV infections. One of these drugs, lamivudine, has been approved to treat hepatitis B, which uses reverse transcriptase as part of its replication process. Researchers have gone further and developed inhibitors that do not look like nucleosides, but can still block reverse transcriptase. Another target being considered for HIV antivirals include RNase H—which is a component of reverse transcriptase that splits the synthesized DNA from the original viral RNA.
J.J. Thomson (1897) "Cathode Rays", The Electrician 39, 104, also published in Proceedings of the Royal Institution 30 April 1897, 1–14 – first announcement of the "corpuscle" (before the classic mass and charge experiment) J.J. Thomson (1897), Cathode rays, Philosophical Magazine, 44, 293 – the classic measurement of the electron mass and charge J.J. Thomson (1904), "On the Structure of the Atom: an Investigation of the Stability and Periods of Oscillation of a number of Corpuscles arranged at equal intervals around the Circumference of a Circle; with Application of the Results to the Theory of Atomic Structure," Philosophical Magazine Series 6, Volume 7, Number 39, pp. 237–265. This paper presents the classical "plum pudding model" from which the Thomson Problem is posed. J. J. Thomson (1906). "On the Number of Corpuscles in an Atom" (PDF). Philosophical Magazine. 6. 11 (66): 769–781. doi:10.1080/14786440609463496. Joseph John Thomson (1908). On the Light Thrown by Recent Investigations on Electricity on the Relation Between Matter and Ether: The Adamson Lecture Delivered at the University on November 4, 1907. University Press. J.J. Thomson (1912), "Further experiments on positive rays" Philosophical Magazine, 24, 209–253 – first announcement of the two neon parabolae J.J. Thomson (1913), Rays of positive electricity, Proceedings of the Royal Society, A 89, 1–20 – discovery of neon isotopes J.J. Thomson (1923), The Electron in Chemistry: Being Five Lectures Delivered at the Franklin Institute, Philadelphia. Thomson, Sir J. J.
== History == 2,5-DMA was first described in the scientific literature by F. Benington and colleagues by at least 1968. Subsequently, it was described in greater detail by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).
Sources: en.wikipedia.org
Truveta, Inc. is an American health data and analytics company headquartered in Bellevue, Washington and owned and governed by 30 U.S. health systems. Truveta was established in 2020 by Providence, Advocate Health, Tenet Healthcare, and Trinity Health. The company was publicly introduced in February 2021 with fourteen founding health system members. As of 2025, Truveta includes 30 U.S. health systems as members. Truveta provides de-identified electronic health record data for more than 120 million U.S. patients.
The structure of somatostatin receptor antagonists is similar to that of the agonists. Some agonists were already approved by the FDA for clinical use, such as In-DTPA-octreotide and Ga-DOTATATE. Development started after the discovery of modifications that can be done to the octreotide group, an ssrt selective subtype agonist, to cause its agonistic effects to be lost and gain antagonistic effects. Different subtype receptor antagonists were later developed. Research has been done mostly on the sstr2 receptor antagonist, as the sstr2 receptor is expressed on most tumors. Somatostatin receptor antagonists are divided by generation based on the type of the subtype receptor antagonist. The first generation consists of sst2-ANT and BASS, which are sstr2 selective; and sst3-ODAN-8, which is selective for sstr3. After initial results of their increased sensitivity to neurocrine tumors appeared, ssrt2 selective antagonists that had even higher affinity were developed. These were LM3, JR10, and JR11, which make up the second generation. JR11 was shown to be the most effective among these 3 antagonists, and compounds that entered further clinical development to act as a PET imaging agent or therapeutic agent carried this subtype antagonist. The presence of a chelator coupled to the subtype antagonist was shown to affect the biological properties., by increasing the binding stability of the radionuclide to the rest of the compound, and increasing the binding affinity to the receptor by allowing conjugation of the radionuclide to the receptor.
Every mission demonstrated the ability to adjust the crafts' inclination and apsis without issue. Gemini 5 demonstrated eight-day endurance, long enough for a round trip to the Moon. Gemini 7 demonstrated a fourteen-day endurance flight. Gemini 6A demonstrated rendezvous and station-keeping with Gemini 7 for three consecutive orbits at distances as close as 1 foot (0.30 m). Gemini 9A also achieved rendezvous with an Agena Target Vehicle (ATV). Rendezvous and docking with the ATV was achieved on Gemini 8, 10, 11, and 12. Gemini 11 achieved the first direct-ascent rendezvous with its Agena target on the first orbit. Extravehicular activity (EVA) was perfected through increasing practice on Gemini 4, 9A, 10, 11, and 12. On Gemini 12, Edwin "Buzz" Aldrin spent over five hours working comfortably during three (EVA) sessions, finally proving that humans could perform productive tasks outside their spacecraft. Gemini 10, 11, and 12 used the ATV's engine to make large changes in its orbit while docked. Gemini 11 used the Agena's rocket to achieve a crewed Earth orbit record apogee of 742 nautical miles (1,374 km). Gemini 8 experienced the first in-space mission abort on March 17, 1966, just after achieving the world's first docking, when a stuck or shorted thruster sent the craft into an uncontrolled spin. Command pilot Neil Armstrong was able to shut off the stuck thruster and stop the spin by using the re-entry control system. He and his crewmate David Scott landed and were recovered safely. Most of the novice pilots on the early missions would command the later missions.
== Venom and apitherapy == The main component of bee venom responsible for pain in vertebrates is the toxin melittin; histamine and other biogenic amines may also contribute to pain and itching. In one of the alternative medical uses of honey bee products, apitherapy, bee venom has been used to treat arthritis and other painful conditions. All currently available evidence supporting this practice is either anecdotal, animal studies, or preliminary evidence, most of which has poor methodology. Apitherapy is not currently accepted as a viable medical treatment for any condition or disease; the risk of allergic reaction and anaphylaxis outweighs any benefits. According to the American Cancer Society, there is no scientific evidence that apitherapy or bee venom therapy can treat or change the course of cancer or any other disease. Clinical trials have shown that apitherapy is ineffective in treating multiple sclerosis or any other disease, and can exacerbate multiple sclerosis symptoms.
Ultrasound-assisted extractive electrospray ionization mass spectrometry (EESI-MS) has been developed at ETH Zurich (Switzerland) by Zhu, Chingin et al., (2008) for a rapid detection of melamine in untreated food samples. Ultrasounds are used to nebulize the melamine-containing liquids into a fine spray. The spray is then ionised by extractive electrospray ionisation (EESI) and analysed using tandem mass spectrometry (MS/MS). An analysis requires 30 seconds per sample. The limit of detection of melamine is a few nanograms of melamine per gram of milk. Huang et al. (2008) have also developed at Purdue University (US) a simpler instrumentation and a faster method by using a low-temperature plasma probe to ionize the samples. The major obstacles being solved, the ESI-MS technique allows now high-throughput analysis of melamine traces in complex mixtures. The Melaminometer was a hypothetical design for a synthetic biology circuit, to be used for detecting melamine and related chemical analogues such as cyanuric acid. The conceptual project is hosted at OpenWetWare as open source biology in collaboration with DIYbio and has been discussed in various newspapers in the context of homebrew biotechnology. As of October 2009, the design has not been verified. Because melamine resin is often used in food packaging and tableware, melamine at ppm level (1 part per million) in food and beverage has been reported due to migration from melamine-containing resins.
Sources: en.wikipedia.org
Yet Bacillus subtilis inoculation may provide some benefit to growers by speeding corm growth and increasing stigma biomass yield. The plants fare poorly in shady conditions; they grow best in full sunlight. Fields that slope towards the sunlight are optimal (i.e., south-sloping in the Northern Hemisphere). Planting is mostly done in June in the Northern Hemisphere, where corms are lodged 7–15 cm (3–6 in) deep; its roots, stems, and leaves can develop between October and February. Planting depth and corm spacing, in concert with climate, are critical factors in determining yields. Mother corms planted deeper yield higher-quality saffron, though they form fewer flower buds and daughter corms. Italian growers optimise thread yield by planting 15 cm (6 in) deep and in rows 2–3 cm (3⁄4–1+1⁄4 in) apart; depths of 8–10 cm (3–4 in) optimise flower and corm production. Greek, Moroccan, and Spanish growers employ distinct depths and spacings that suit their locales. C. sativus prefers friable, loose, low-density, well-watered, and well-drained clay-calcareous soils with high organic content. Traditional raised beds promote good drainage. Soil organic content was historically boosted via application of some 20–30 tonnes per hectare (9–13 short tons per acre) of manure. Afterwards, and with no further manure application, corms were planted. After a period of dormancy through the summer, the corms send up their narrow leaves and begin to bud in early autumn. Only in mid-autumn do they flower.
== Neutron poisoning == A reactor can be unintentionally "shut down" by having an excess of neutron poisons in the reactor vessel. Neutron poisons are chemical byproducts of the nuclear reaction which absorb neutrons, lowering reactivity in the reactor and potentially stalling the reaction if enough poisons are allowed to build up. An example of this would be the Chernobyl disaster in 1986, when Reactor No. 4 suffered from a serious xenon-135 poisoning, which pushed the reactor into an unstable condition which later caused the accident. While neutron poisoning is not considered a shutdown in and of itself, it often requires that the reactor be shut down while the poisons are flushed from the system, as they can destabilise the reactor and cause it to behave unpredictably. Certain reactors, such as the CANDU reactor design (where it is called EPIS, or Emergency Poison Injection System), employ this phenomenon as part of their SCRAM procedure. When a SCRAM occurs, neutron poisons are injected into the reactor to immediately lower the reactivity of the reactor, at the same time or slightly prior to other shutdown mechanisms, such as control rods.
=== Drugs of abuse === Synthetic cannabinoids Cocaine LSD Opiates (e.g., fentanyl, oxycodone, heroin, codeine, and morphine) Amphetamines (e.g., MDMA (Ecstasy), MDA, Meth) "Bath salts" (e.g., cathinone, synthetic cathinone, MDPV) GHB Phencyclidine (PCP)
On 17 May 2022, militias attacked a civilian helicopter that was flying over the Rio area with rifles. No injuries were recorded but the helicopter suffered slight damage. On 20 August of the same year, Delson Lima Neto, brother of one of the leader of the militias, Tandera Danilo Dias Lima, was killed alongside 3 paramilitaries soldiers by the Polícia Militar on Nova Iguaçu, in Baixada Fluminense, after his death the Comando Vermelho conquered the favela of Grão-Pará, in Nova Iguaçu. After the raid, on 23 August, the police found and seized an improvised fighting vehicle (similar to a Caveirão) used by the militias to fight against Comando Vermelho in Nova Iguaçu. According to law student Carlos Gilberto Martins Junior of Brazil in 2023, with emphasis on the State of Rio de Janeiro, there has been an arbitrary use of these powers and attributions, conferred on police institutions, to satisfy the patrimonial aspirations of some of its agents, through territorial domination and violence, to the detriment of the peripheral communities and under the pretext of saving them from the "greater evil" represented by drug trafficking, corroborating the emergence of criminals organizations what conventionally called the "militia". On 6 May 2021, at least 29 people were killed in a shootout between gangsters of Comando Vermelho and police. On May 24 2022, the BOPE raided the Vila Cruzeiro favela in Penha Complex, killing 26 people between civilians and gangsters of Comando Vermelho.
Sources: en.wikipedia.org
The lyophilized powder is commonly kept at -20 °C or lower, protected from moisture and light. Solutions may require colder storage and should avoid repeated freeze-thaw cycles. General peptide stability practices apply.
Reverse-phase HPLC can estimate purity, while mass spectrometry helps confirm molecular mass. These methods do not prove biological effects. Lot-specific certificates may provide additional data.
It is not an approved medicine in major jurisdictions. Depending on the country and marketing claims, it may be treated as a research chemical or unapproved substance. Import and sale rules vary.
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.